---
document_datetime: 2023-09-21 19:14:38
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/olanzapine-cipla-epar-all-authorised-presentations_en.pdf
document_name: olanzapine-cipla-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.5731196
conversion_datetime: 2025-12-18 09:41:58.304277
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| EU Number       | Name                 | Strength   | Pharmaceutical Form   | Route of Administration   | Packaging                    |   Package size |
|-----------------|----------------------|------------|-----------------------|---------------------------|------------------------------|----------------|
| EU/1/07/426/001 | Olanzapine Neopharma | 2.5 mg     | Coated Tablet         | Oral use                  | authorised Blister (alu/alu) |             28 |
| EU/1/07/426/002 | Olanzapine Neopharma | 2.5 mg     | Coated Tablet         | Oral use                  | Blister (alu/alu)            |             56 |
| EU/1/07/426/003 | Olanzapine Neopharma | 5 mg       | Coated Tablet         | Oral use                  | Blister (alu/alu)            |             28 |
| EU/1/07/426/004 | Olanzapine Neopharma | 5 mg       | Coated Tablet         | Oral use                  | Blister (alu/alu)            |             56 |
| EU/1/07/426/005 | Olanzapine Neopharma | 7.5 mg     | Coated Tablet         | Oral use                  | Blister (alualu)             |             28 |
| EU/1/07/426/006 | Olanzapine Neopharma | 7.5 mg     | Coated Tablet         | Oral use                  | Blister (alu)/alu            |             56 |
| EU/1/07/426/007 | Olanzapine Neopharma | 10 mg      | Coated Tablet         | Oral use                  | Blister (alualu)             |              7 |
| EU/1/07/426/008 | Olanzapine Neopharma | 10 mg      | Coated Tablet         | Oral use                  | Blister (alu/alu)            |             28 |
| EU/1/07/426/009 | Olanzapine Neopharma | 10 mg      | Coated Tablet         | Oral use                  | Blister (alu/alu)            |             56 |
| EU/1/07/426/010 | Olanzapine Neopharma | 15 mg      | Coated Tablet         | Oral use                  | Blister (alu/alu)            |             28 |
| EU/1/07/426/011 | Olanzapine Neopharma | 15 mg      | Coated Tablet         | Oral use                  | Blister (alu/alu)            |             56 |

Medicinal product no longer authorised Strength Pharmaceutical Form Route of Administration Packaging 2.5 mg Coated Tablet Oral use Blister (alu/alu) 2.5 mg Coated Tablet Oral use Blister (alu/alu) 5 mg Coated Tablet Oral use Blister (alu/alu) 5 mg Coated Tablet Oral use Blister (alu/alu) 7.5 mg Coated Tablet Oral use Blister (alualu) 7.5 mg Coated Tablet Oral use Blister (alu)/alu 10 mg Coated Tablet Oral use Blister (alualu) 10 mg Coated Tablet Oral use Blister (alu/alu) 10 mg Coated Tablet Oral use Blister (alu/alu) 15 mg Coated Tablet Oral use Blister (alu/alu) 15 mg Coated Tablet Oral use Blister (alu/alu)